BD: A Global Leader in Technology Innovation
BD was one of the first medical technology companies to innovate new capture and control technologies to further reduce EtO emissions from our sterilization facilities.
BD was one of the first medical technology companies to innovate new capture and control technologies to further reduce EtO emissions from our sterilization facilities.
BD was one of the first medical technology companies to innovate new capture and control technologies to further reduce EtO emissions from our sterilization facilities.
BD has led the industry in recent years by conducting studies to better understand residual emissions from sterilized products and by implementing new EtO capture and control technologies to significantly reduce these emissions.
BD installed new EtO emission capture technologies at our Georgia facilities. These systems proved to be effective, and BD installed similar systems at each of our EtO facilities across the U.S.
Over the past decades, BD has voluntarily upgraded our facilities with the best available technology to reduce emissions. BD is continuing this track record through significant investments for further upgrades at all of our U.S. EtO sterilization facilities.
BD is an industry leader in the implementation of capture and control technologies to reduce EtO emissions at our sterilization facilities. At every step of the sterilization process, safety is our top priority.
1. Preconditioning
Product is loaded into a specialized room or cell where it is exposed to heat and humidity within a specific range to condition the product prior to sterilization. No EtO is used during the preconditioning phase.
2. Sterilization
Product is moved by conveyor into an air-tight specialized sterilization chamber where it is treated with EtO gas under vacuum. This renders the product sterile. All exhaust from the chamber is sent to the oxidizer for treatment of emissions.
3. Aeration
Product is then moved by conveyor into a specialized cell where heated air is used to remove residual EtO. After aeration, the product is tested to ensure that it meets FDA sterility and EtO residual requirements. The exhaust from the aeration cell is sent to the oxidizer for treatment.
4. Warehouse Storage
Once the aeration process is complete, the product is moved to the post-sterile warehouse where dry bed treatment technology is installed to treat trace amounts of EtO that diffuse from sterilized product.
BD tested and installed newly developed emissions controls that meet the EPA’s new risk threshold at all of our EtO sterilization facilities nationwide.
Used by BD facilities as the primary EtO emission control equipment. Through the oxidation process, EtO is converted into carbon dioxide and water.
Designed to control residual emissions from gas rooms, sterilizer rooms, and post-sterile warehouses through means of absorption.
Designed to minimize EtO emissions throughout the sterilization process.
